Cancer medicine · 2026
Metformin-Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jinadasa Ambulugala Gamage Rajika Greshamali, Wageesha N D Amal, Samarakoon Sameera R, Ekanayake Sagarika, Akalanka H M Kasuni
Аннотация
INTRODUCTION: Metformin, the common anti-hyperglycemic agent, is emerging with pharmacological significance as an effective anti-cancer modulator. Its efficacy as an anti-cancer modulator is reported in pre-clinical and clinical studies. Therefore, an attempt was made to identify the possible in vitro anti-cancer molecular mechanisms studied on breast cancer (BC) cell lines.
METHODS: An advanced literature search was conducted in the PubMed database using search terms "Metformin, Cell culture, Breast neoplasms." Different anti-cancer molecular mechanisms induced by metformin (MET) identified in cell culture studies are presented in this paper.
RESULTS: It was identified that MET induces molecular pathways that exert anti-cancer effects when treated on BC cells. Inhibition of oxidative phosphorylation, adenosine monophosphate-activated protein kinase mediated anticancer effects, anti-proliferation and inhibition of cell migration, alteration of tumor micro-environment, synergetic effects with conventional chemotherapies and other potential molecules, induced apoptosis and ferroptosis were mainly identified as MET-induced pathways that affect BC cells.
CONCLUSION: Metformin induces diverse anti-cancer biochemical pathways through which it exhibits a potential to be used as an anti-cancer therapeutic in BC.
METHODS: An advanced literature search was conducted in the PubMed database using search terms "Metformin, Cell culture, Breast neoplasms." Different anti-cancer molecular mechanisms induced by metformin (MET) identified in cell culture studies are presented in this paper.
RESULTS: It was identified that MET induces molecular pathways that exert anti-cancer effects when treated on BC cells. Inhibition of oxidative phosphorylation, adenosine monophosphate-activated protein kinase mediated anticancer effects, anti-proliferation and inhibition of cell migration, alteration of tumor micro-environment, synergetic effects with conventional chemotherapies and other potential molecules, induced apoptosis and ferroptosis were mainly identified as MET-induced pathways that affect BC cells.
CONCLUSION: Metformin induces diverse anti-cancer biochemical pathways through which it exhibits a potential to be used as an anti-cancer therapeutic in BC.